These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22723444)

  • 1. Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction.
    Cheng J; Garcia V; Ding Y; Wu CC; Thakar K; Falck JR; Ramu E; Schwartzman ML
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1917-24. PubMed ID: 22723444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent.
    Sodhi K; Wu CC; Cheng J; Gotlinger K; Inoue K; Goli M; Falck JR; Abraham NG; Schwartzman ML
    Hypertension; 2010 Nov; 56(5):871-8. PubMed ID: 20837888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.
    Garcia V; Joseph G; Shkolnik B; Ding Y; Zhang FF; Gotlinger K; Falck JR; Dakarapu R; Capdevila JH; Bernstein KE; Schwartzman ML
    Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(1):R71-8. PubMed ID: 25924878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter Binding.
    Garcia V; Shkolnik B; Milhau L; Falck JR; Schwartzman ML
    J Pharmacol Exp Ther; 2016 Mar; 356(3):525-33. PubMed ID: 26699146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling.
    Cheng J; Wu CC; Gotlinger KH; Zhang F; Falck JR; Narsimhaswamy D; Schwartzman ML
    J Pharmacol Exp Ther; 2010 Jan; 332(1):57-65. PubMed ID: 19841472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase.
    Wu CC; Cheng J; Zhang FF; Gotlinger KH; Kelkar M; Zhang Y; Jat JL; Falck JR; Schwartzman ML
    Hypertension; 2011 Apr; 57(4):788-94. PubMed ID: 21321301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling.
    Cheng J; Ou JS; Singh H; Falck JR; Narsimhaswamy D; Pritchard KA; Schwartzman ML
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H1018-26. PubMed ID: 18156192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS.
    Garcia V; Cheng J; Weidenhammer A; Ding Y; Wu CC; Zhang F; Gotlinger K; Falck JR; Schwartzman ML
    Prostaglandins Other Lipid Mediat; 2015; 116-117():124-30. PubMed ID: 25526688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation.
    Guo AM; Arbab AS; Falck JR; Chen P; Edwards PA; Roman RJ; Scicli AG
    J Pharmacol Exp Ther; 2007 Apr; 321(1):18-27. PubMed ID: 17210799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (G
    Garcia V; Gilani A; Shkolnik B; Pandey V; Zhang FF; Dakarapu R; Gandham SK; Reddy NR; Graves JP; Gruzdev A; Zeldin DC; Capdevila JH; Falck JR; Schwartzman ML
    Circ Res; 2017 May; 120(11):1776-1788. PubMed ID: 28325781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conflicting roles of 20-HETE in hypertension and renal end organ damage.
    Zhang C; Booz GW; Yu Q; He X; Wang S; Fan F
    Eur J Pharmacol; 2018 Aug; 833():190-200. PubMed ID: 29886242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-mediated regulation of the endothelial renin-angiotensin system and vascular cell growth.
    Kamide K; Rakugi H; Nagai M; Takiuchi S; Matsukawa N; Higaki J; Kawano Y; Ogihara T; Tuck ML
    J Hypertens; 2004 Jan; 22(1):121-7. PubMed ID: 15106803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal high-sodium intake affects the offspring' vascular renin-angiotensin system promoting endothelial dysfunction in rats.
    Santos-Rocha J; Lima-Leal GA; Moreira HS; Ramos-Alves FE; de Sá FG; Duarte GP; Xavier FE
    Vascul Pharmacol; 2019 Apr; 115():33-45. PubMed ID: 30790705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
    Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 20-HETE and blood pressure regulation: clinical implications.
    Wu CC; Gupta T; Garcia V; Ding Y; Schwartzman ML
    Cardiol Rev; 2014; 22(1):1-12. PubMed ID: 23584425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 20-HETE in androgen-mediated hypertension.
    Wu CC; Schwartzman ML
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):45-53. PubMed ID: 21722750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 20-HETE can act as a nonhypoxic regulator of HIF-1alpha in human microvascular endothelial cells.
    Guo AM; Scicli G; Sheng J; Falck JC; Edwards PA; Scicli AG
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H602-13. PubMed ID: 19502554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
    Ishiyama Y; Gallagher PE; Averill DB; Tallant EA; Brosnihan KB; Ferrario CM
    Hypertension; 2004 May; 43(5):970-6. PubMed ID: 15007027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.